New vaccine aims to shield vulnerable kids from deadly virus
NCT ID NCT03354728
Summary
This study is testing a new vaccine designed to protect children from serious complications of cytomegalovirus (CMV) after they receive a donor stem cell transplant. The research aims to find the safest and most effective dose of the vaccine and see if it can reduce CMV infections compared to past cases. About 80 children who are CMV-positive and undergoing a transplant will receive the vaccine shots after their procedure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRAL INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.